First-line treatment of advanced ALK-positive non-small-cell lung cancer
Shipra Gandhi,1 Hongbin Chen,2 Yujie Zhao,2 Grace K Dy2 1Department of Internal Medicine, State University of New York, 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Abstract: Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths, both within th...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-09-01
|
Series: | Lung Cancer : Targets and Therapy |
Online Access: | https://www.dovepress.com/first-line-treatment-of-advanced-alk-positive-non-small-cell-lung-canc-peer-reviewed-article-LCTT |